Scientists have reconstructed how acute myeloid leukemia (AML) develops over the decades before diagnosis, showing that in two-thirds of cases the first cancer-driving mutation had been acquired before the age of 20—more than 50 years before diagnosis.
Results for “fossil fuels”
A previously unknown mechanism helps cancer cells selectively produce proteins that drive tumor growth—such as KRAS—in common cancers, according to new research from The University of Texas MD Anderson Cancer Center. The findings reveal that targeting a specific enzyme may improve responses to targeted therapies and help overcome treatment resistance.
Up to three-quarters of all women will experience a genital yeast infection at least once in their lives. Recurrent infections, in particular, can significantly impair quality of life. The typical symptoms—such as itching, burning, and pain—are caused not only by the yeast Candida albicans, but, more importantly, by an excessive immune response. But why is the immune reaction in these cases so intense and persistent? An international research team led by the Leibniz-HKI has now uncovered how the host protein albumin fuels the inflammatory cascade while simultaneously shielding the fungal pathogen from the immune system. The findings have been published in Nature Communications.


